Litigation
Ascendis Pharma A/S v. BioMarin Pharmaceutical Inc.
settled4:25-cv-05696
- Terminated
- 2026-08-30
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Declaratory-judgment/safe-harbor action by Ascendis Pharma A/S against BioMarin involving §271(e)(1) and a forum dispute with the parallel ITC action. US 8,377,884 was cited in BioMarin's filings as Exhibit 32 in connection with Ascendis's ITC prior-art/protest arguments concerning RE'267, not as an asserted patent. Resolved by the August 30, 2026 global settlement.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).